{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:11:29Z","timestamp":1777695089683,"version":"3.51.4"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2016001"],"award-info":[{"award-number":["2016001"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Systemic sclerosis (SSc) is a heterogenous disorder that appears to result from interplay between vascular pathologies, tissue fibrosis and immune processes, with evidence for deregulation of chemokines, which normally control immune trafficking. We recently identified altered levels of chemokine CCL21 in SSc associated pulmonary arterial hypertension (PAH). Here, we aimed to define target organ expression and biomarker characteristics of CCL21.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>To investigate target organ expression of CCL21, we performed immunohistochemistry (IHC) on explanted lung tissues from SSc-PAH patients. We assessed serum levels of CCL21 by ELISA and Luminex in two well-characterized SSc cohorts from Oslo (OUH, n=552) and Zurich (n=93) University hospitals and in 168 healthy controls. For detection of anti-CCl21 antibodies, we performed protein array analysis applying serum samples from SSc patients (n=300) and healthy controls. To characterize circulating CCL21 in SSc, we applied immunoprecipitation (IP) with antibodies detecting both full length and tailless and a custom-made antibody detecting only the C-terminal of CCL21. IP products were analyzed by SDS-PAGE\/western blot and Mass spectrometry (MS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>By IHC, we found that CCL21 was mainly expressed in the airway epithelial cells of SSc patients with PAH. In the analysis of serum levels of CCL21 we found weak correlation between Luminex and ELISA (r=0.515, p&amp;lt;0.001). Serum levels of anti-CCL21 antibodies were higher in SSc patients than in healthy controls (p&amp;lt;0.001), but only 5% of the SSc population were positive for anti-CCL21 antibodies in SSc, and we found no correlation between anti-CCl21 and serum levels of CCL21. By MS, we only identified peptides located within amino acid (aa) 23-102 of CCL21, indicating that CCL21 in SSc circulate as a truncated protein without the C-terminal tail.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study demonstrates expression of CCL21 in epithelial lung tissue from SSc patients with PAH, and indicate that CCL21 in SSc circulates as a truncated protein. We extend previous observations indicating biomarker potential of CCL21, but find that Luminex is not suitable as platform for biomarker analyses. Finally, <jats:italic>in vivo<\/jats:italic> generated anti-CCL21 antibodies exist in SSc, but do not appear to modify serum CCL21 levels in patients with SSc-PAH.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.991743","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T18:00:04Z","timestamp":1663956004000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension"],"prefix":"10.3389","volume":"13","author":[{"given":"Henriette","family":"Didriksen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8yvind","family":"Molberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vyacheslav","family":"Palchevskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5vard","family":"Fretheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar","family":"Gude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathrine","family":"Brunborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torhild","family":"Garen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8yvind","family":"Midtvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne K.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fridtjof","family":"Lund-Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Belperio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.04.001","article-title":"Genetics, epigenetics, and genomics of systemic sclerosis","volume":"41","author":"Salazar","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.12703\/r\/10-43","article-title":"Emerging treatments for scleroderma\/systemic sclerosis","volume":"10","author":"Zhu","year":"2021","journal-title":"Fac Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08815-8","article-title":"Serum markers of cardiac complications in a systemic sclerosis cohort","volume":"12","author":"Tenn\u00f8e","year":"2022","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.40815","article-title":"Performance of candidate serum biomarkers for systemic sclerosis\u2013associated interstitial lung disease","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/2397198319894851","article-title":"Circulating biomarkers of systemic sclerosis - interstitial lung disease","volume":"5","author":"Hoffmann-Vold","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3109\/s101650200019","article-title":"Chemokines and chemokine receptors in the pathogenesis of systemic sclerosis","volume":"12","author":"Distler","year":"2002","journal-title":"Modern Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"Van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.chest.2016.03.004","article-title":"High level of chemokine CCL18 is associated with pulmonary function deterioration, lung fibrosis progression, and reduced survival in systemic sclerosis","volume":"150","author":"Hoffmann-Vold","year":"2016","journal-title":"Chest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0206545","DOI":"10.1371\/journal.pone.0206545","article-title":"Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis","volume":"13","author":"Hoffmann-Vold","year":"2018","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa026","article-title":"Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort","volume":"59","author":"Fretheim","year":"2020","journal-title":"Rheumatol (Oxford England)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-015-0517-5","article-title":"A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis","volume":"17","author":"Hao","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200909-1331PP","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"181","author":"Le Pavec","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mvr.2017.06.005","article-title":"Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension","volume":"114","author":"Corrado","year":"2017","journal-title":"Microvasc Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/art.40534","article-title":"CCL21 as a potential serum biomarker for pulmonary arterial hypertension in systemic sclerosis","volume":"70","author":"Hoffmann-Vold","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2013.03.001","article-title":"A myriad of functions and complex regulation of the CCR7\/CCL19\/CCL21 chemokine axis in the adaptive immune system","volume":"24","author":"Comerford","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19188","article-title":"Differential regulation of CCL21 in lymphoid\/nonlymphoid tissues for effectively attracting T cells to peripheral tissues","volume":"112","author":"Lo","year":"2003","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00048.2010","article-title":"Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation","volume":"301","author":"Larsen","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200312-1686OC","article-title":"Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension","volume":"170","author":"Bull","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201105-0927OC","article-title":"Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension","volume":"185","author":"Perros","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025390","article-title":"Modulation of endothelial bone morphogenetic protein receptor type 2 activity by vascular endothelial growth factor receptor 3 in pulmonary arterial hypertension","volume":"135","author":"Hwangbo","year":"2017","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.41665","article-title":"Association of lymphangiogenic factors with pulmonary arterial hypertension in systemic sclerosis","volume":"73","author":"Didriksen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6534","article-title":"Chemokine (C-c motif) ligand 21\/C-c chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial-mesenchymal transition via the extracellular signal-regulated kinase signaling pathway","volume":"15","author":"Zhong","year":"2017","journal-title":"Mol Med Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2000.17721.x","article-title":"The strategy of blocking the chemokine system to combat disease","volume":"177","author":"Proudfoot","year":"2000","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0252805","DOI":"10.1371\/journal.pone.0252805","article-title":"A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease","volume":"16","author":"Capitano","year":"2021","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0511200103","article-title":"Secondary lymphoid tissue chemokine (SLC\/CCL21)\/CCR7 signaling regulates fibrocytes in renal fibrosis","volume":"103","author":"Sakai","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-020-02180-0","article-title":"Autoantibodies against cytokines: phenocopies of primary immunodeficiencies","volume":"139","author":"Ku","year":"2020","journal-title":"Hum Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01203-3","article-title":"Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital","volume":"42","author":"Chauvineau-Grenier","year":"2021","journal-title":"J Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320935976","article-title":"Characterization of type-I IFN subtype autoantibodies and activity in SLE serum and urine","volume":"29","author":"Harris","year":"2020","journal-title":"Lupus"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.12.7118","article-title":"Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7","volume":"273","author":"Yoshida","year":"1998","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: Balancing immunity and tolerance","volume":"8","author":"F\u00f6rster","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00568","article-title":"Differential CCR7 targeting in dendritic cells by three naturally occurring CC-chemokines","volume":"7","author":"Hjort\u00f8","year":"2016","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2005.11.010","article-title":"Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA","volume":"38","author":"Elshal","year":"2006","journal-title":"Methods"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.081679","article-title":"Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid \u03b242 and tau proteins","volume":"53","author":"Reijn","year":"2007","journal-title":"Clin Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-120082","article-title":"Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of alzheimer\u2019s disease","volume":"31","author":"Wang","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140047","article-title":"Performance of the 2013 American college of Rheumatology\/European league against rheumatism classification criteria for systemic sclerosis (SSc) in Large, well-defined cohorts of SSc and mixed connective tissue disease","volume":"42","author":"Hoffmann-Vold","year":"2015","journal-title":"J Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: An American college of Rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex435","article-title":"Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: Results from a prospective systemic sclerosis cohort","volume":"57","author":"Hoffmann-Vold","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): Endorsed by: Association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT)","volume":"37","author":"Galie","year":"2016","journal-title":"J Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1183\/09031936.00157508","article-title":"CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis","volume":"34","author":"Busuttil","year":"2009","journal-title":"Eur Respir J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142489","article-title":"EUSTAR biobanking: Recommendations for the collection, storage and distribution of biospecimens in scleroderma research","volume":"70","author":"Beyer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key285","article-title":"Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides","volume":"58","author":"Garen","year":"2019","journal-title":"Rheumatology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0179-8","article-title":"A high-throughput pipeline for validation of antibodies","volume":"15","author":"Sikorski","year":"2018","journal-title":"Nat Methods"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nri3739","article-title":"The role of airway epithelial cells and innate immune cells in chronic respiratory disease","volume":"14","author":"Holtzman","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2737","article-title":"The airway epithelium in asthma","volume":"18","author":"Lambrecht","year":"2012","journal-title":"Nat Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0193334","DOI":"10.1371\/journal.pone.0193334","article-title":"Chemokine expression in the early response to injury in human airway epithelial cells","volume":"13","author":"Xie","year":"2018","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12931-021-01708-w","article-title":"The alveolar epithelial cells are involved in pulmonary vascular remodeling and constriction of hypoxic pulmonary hypertension","volume":"22","author":"Wang","year":"2021","journal-title":"Respir Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"PA2440","DOI":"10.1183\/13993003.congress-2016.PA2440","article-title":"Pulmonary arterial hypertension and continuous injury of alveolar epithelial cells in COPD","volume":"48","author":"Yazaki","year":"2016","journal-title":"Eur Respir J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044941","article-title":"Airway epithelial cells condition dendritic cells to express multiple immune surveillance genes","volume":"7","author":"Rate","year":"2012","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0033ED","article-title":"Macrophage regulation during vascular remodeling: Implications for pulmonary hypertension therapy","volume":"56","author":"Pullamsetti","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03235-w","article-title":"CCL21\/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis","volume":"77","author":"Van Raemdonck","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-011-0517-7","article-title":"The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases","volume":"6","author":"Murdaca","year":"2011","journal-title":"Internal Emergency Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"6600264","DOI":"10.1155\/2022\/6600264","article-title":"A mechanistic insight into the pathogenic role of interleukin 17A in systemic autoimmune diseases","volume":"2022","author":"Bisoendial","year":"2022","journal-title":"Med Inflamm"},{"key":"B59","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.885609","article-title":"The yin and yang of IL-17 in systemic sclerosis","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1678","article-title":"T-helper 17 cell polarization in pulmonary arterial hypertension","volume":"147","author":"Hautefort","year":"2015","journal-title":"Chest"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03946320140270S101","article-title":"The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases","volume":"27","author":"Blandizzi","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1179\/1351000213Y.0000000046","article-title":"Free radicals and endothelial dysfunction: Potential positive effects of TNF-\u03b1 inhibitors","volume":"18","author":"Murdaca","year":"2013","journal-title":"Redox Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2217\/imt.13.173","article-title":"Potential use of TNF-\u03b1 inhibitors in systemic sclerosis","volume":"6","author":"Murdaca","year":"2014","journal-title":"Immunotherapy"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636218","article-title":"TNF-dependent overexpression of CCL21 is an underlying cause of progressive lymphoaccumulation in generalized lymphoproliferative disorder","volume":"37","author":"Wiede","year":"2007","journal-title":"Eur J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.991743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T18:00:06Z","timestamp":1663956006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.991743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2022.991743"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.991743","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"991743"}}